CDSCO Strategy & Documentation Support
Independent support for India medical device pathway assessment, documentation readiness, and biocompatibility-related regulatory planning under MDR 2017, delivered on selected projects with India-specific collaboration where required.
Pathway Assessment
Focused support on classification logic, route-to-market questions, and India-specific planning under MDR 2017.
Documentation Readiness
Review of technical and biocompatibility documentation for likely gaps before formal India submission work moves forward.
Biocompatibility Support
Support on applicable IS/ISO 10993 expectations and evidence framing where biological evaluation is part of the India strategy.
Cross-Market Planning
Useful when the India strategy needs to stay aligned with parallel EU MDR or FDA documentation work.
Best for teams that need India planning and documentation support without inflated claims
This service fits manufacturers, importers, startups, and regulatory teams that need independent support on India pathway planning, documentation readiness, or biocompatibility-linked submission preparation. It is intentionally narrower than a broad “all CDSCO services” promise.
Classification and Pathway Questions
You need a clearer view of the likely regulatory route, applicant structure, or documentation path before more work is commissioned.
Documentation Readiness Check
You already have technical or biocompatibility material and want to understand whether it is directionally usable for an India submission strategy.
India + FDA / EU Coordination
You want the India plan to stay coherent with ongoing EU MDR or FDA work rather than creating disconnected documentation streams.
Selected Specialist Collaboration
The project needs India-specific execution depth, so scoped work is handled with collaboration from experienced specialists where appropriate.
What can be included in a CDSCO-related scope
The point here is not a broad India claim. It is clearly scoped support on documentation, pathway questions, and cross-market regulatory strategy.
Classification and Route Review
Initial assessment of device category, likely route, and planning questions under the India medical device framework.
Technical Documentation Readiness
Review of whether the current file set is directionally usable or whether obvious India-specific gaps need to be addressed first.
Biocompatibility Documentation Support
Support on applicable IS/ISO 10993-aligned evidence framing where biological evaluation is relevant to the device and submission path.
Cross-Market Alignment
Useful where one documentation strategy needs to stay coherent across India, EU MDR, and FDA workstreams.
Gap Analysis Before Filing Work
Helps teams decide whether they need minor adaptation, substantial remediation, or specialist execution support.
Collaboration-Backed Execution
Where India-specific execution needs deeper local regulatory experience, the project can be handled under a defined collaboration model.
Simple scoping first, then a defined project model
The goal is to avoid broad promises. First confirm what the actual India scope is, then decide whether founder-led support alone is sufficient or whether collaboration is needed.
Describe the Device and Goal
Share the device type, intended use, materials, target route, and whether India is a primary or secondary market in the broader plan.
Assess the Real Scope
Decide whether the need is pathway planning, documentation readiness, biocompatibility support, or a wider India-specific execution issue.
Define the Delivery Model
Where appropriate, the project stays founder-led with collaboration from experienced India specialists for the narrower execution layer.
Proceed on a Scoped Basis
The work moves forward only after scope, boundaries, and responsibilities are clear. No official or implied government relationship is claimed.
Important questions to answer clearly
Are you affiliated with or endorsed by CDSCO?
No. MedDev Advisory provides independent consulting support and is not affiliated with, endorsed by, or approved by CDSCO or the Government of India.
Does this mean you act as an authorized agent?
No, not by default. If a project requires roles beyond independent advisory support, that must be discussed and defined separately.
Can you support biocompatibility-related documentation for India?
Yes, where the project requires documentation planning tied to applicable IS/ISO 10993 expectations and broader device-safety support.
Why is this positioned as selected-project support?
Because the goal is to keep the offer credible and collaboration-backed rather than making broad public claims before the exact scope is understood.
Discuss whether the CDSCO scope is real, narrow, and worth pursuing.
Send the device type, intended use, current documentation status, and whether India is a primary route or part of a broader global strategy. If the scope is credible, the next step is a defined proposal with clear boundaries.